Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で2900.00%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 420.00Kに達しています。
適正水準
同社の最新のPEは-0.02で、過去3年間の水準と比較して適正圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は1.62M株で、前四半期比で12.19%増加しています。
市場活動が低調
同社への投資家の関心は低下しており、20日間の売買回転率は-0.33です。